Tuesday, April 21, 2026
Home Authors Posts by Ogkologos

Ogkologos

4202 POSTS 0 COMMENTS

FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC with High...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin

Ogkologos -
0

ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act

Ogkologos -
0

Elinzanetant Leads To a Significantly Lower Frequency of Vasomotor Symptoms Associated...

Ogkologos -
0

ESMO Calls for Cancer to Be at the Core of the...

Ogkologos -
0

Better EFS Outcomes with Perioperative Durvalumab Plus FLOT Than with Placebo...

Ogkologos -
0

FDA Approves Belzutifan for Pheochromocytoma or Paraganglioma

Ogkologos -
0

Molecular Determinants of Sotorasib Efficacy in Patients with Advanced KRASG12C-mutated NSCLC

Ogkologos -
0

ESMO Gynaecological Cancers Congress 2025, Vienna, Austria, 19-21 June

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Zanidatamab

Ogkologos -
0
1...282930...421Page 29 of 421

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com